 |
|
|
| |
Enabling clinical development of an HIV attachment inhibitor through innovative pharmaceutical development: novel extended-release delivery of a prodrug
|
| |
| |
Reported by Jules Levin
11th International Congress on Drug Therapy in HIV Infection
Glasgow 2012 Nov 11-14
Jonathan Brown,1 Mike Tobyn,1 Sarah Brown,1 Timothy Connolly,2 Andrew Dennis,1 George J Hanna,3 Helen Hughes,1 John Kadow,2 Nicholas Meanwell,2 Tao Wang,2 Kap-Sun Yeung,2 Li Zhu,4 Peter Timmins,1
1Bristol-Myers Squibb, Research and Development, Moreton, UK; 2Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA; 3Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA, 4Bristol-Myers Squibb, Research and Development, Hopewell, NJ, USA
|
| |
|
|
|
|
|
